Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Regulatory News
3/27/2024
NMPA Holds National Conference on Drug Registration and Post-Market Re...
3/27/2024
NIFDC Issues the 2023 National Drug Sample Inspection Annual Report
3/26/2024
NMPA Publishes the 2023 Annual Report for Adverse Drug Reaction Monito...
3/22/2024
NMPA Announces Package Insert Revision of Multiple Drugs
3/22/2024
CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
3/22/2024
China Eases Cross-Border Data Transfer Rules to Alleviate Concerns of ...
3/19/2024
NDRC Issues 2024 Edition of the Guiding Catalog for Adjustment of Indu...
3/18/2024
CDE Publicizes the List of Reference Formulations for GQCE Studies (80...
3/12/2024
CDE Issues the List of Reference Formulations for GQCE Studies (78th B...
3/6/2024
US Senate Committee Approves Bill That Could Restrict Chinese Biotech
3/6/2024
CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
3/5/2024
NMPA Announces Package Insert Revision of Synovitis Formulations
2/29/2024
CDE Issues the Technical Guidelines for Clinical Trial of Growth Hormo...
2/23/2024
NMPA Issues the Rules for the Application of Discretion in Administra...
2/22/2024
CDE Issues the Technical Guidelines for Non-Clinical Research on Enzym...
2/21/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
2/21/2024
CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
2/21/2024
CDE Publicizes the List of Reference Formulations for GQCE Studies (79...
2/19/2024
CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
2/8/2024
China Issues the Action Plan for National Emergency Clinical Trials fo...
2/7/2024
CDE Issues the Technical Guidelines for Pharmaceutical Research on Mic...
2/7/2024
CDE Issues the Dossier References for Drug R&D and Technical Evaluatio...
2/7/2024
CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
2/7/2024
CDE Issues the List of Reference Formulations for GQCE Studies (77th B...
2/7/2024
NMPA Restores Import, Sales and Use of GSK's BPH Drug
2/7/2024
Boao Lecheng Pilot Zone Experiments Expedited Entry into China's Healt...
2/7/2024
China Proposes Accelerated Approval for Local Production of Biologics
2/7/2024
NMPA Issues the Pilot Reform Work Plan for Optimizing Drug Supplementa...
2/6/2024
NMPA and Chinese Customs Announce Addition of Hefei Airport as a Drug ...
2/6/2024
CDE Issues the Guidelines for Management and Review of Compliance Info...
Page:
1
/
9
Total number of articles:
259
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit